Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

BUY
$11.79 - $27.63 $196,727 - $461,034
16,686 Added 90.93%
35,036 $508,000
Q1 2022

May 11, 2022

SELL
$20.67 - $40.33 $188,283 - $367,365
-9,109 Reduced 33.17%
18,350 $479,000
Q3 2021

Nov 10, 2021

SELL
$49.57 - $58.15 $491,833 - $576,964
-9,922 Reduced 26.54%
27,459 $1.37 Million
Q2 2021

Aug 10, 2021

BUY
$47.17 - $58.64 $48,396 - $60,164
1,026 Added 2.82%
37,381 $2.08 Million
Q1 2021

May 14, 2021

BUY
$42.51 - $54.07 $224,282 - $285,273
5,276 Added 16.98%
36,355 $1.7 Million
Q4 2020

Feb 11, 2021

BUY
$31.9 - $44.89 $991,420 - $1.4 Million
31,079 New
31,079 $1.35 Million

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $378M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.